Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05800275
Title Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease (ETIC-LM)
Acronym ETIC-LM
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors UNICANCER
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
Institut Bergonié NOT_YET_RECRUITING Bordeaux 33000 France Details
Centre François Baclesse RECRUITING Caen 14000 France Details
Centre Jean Perrin RECRUITING Clermont-Ferrand 63011 France Details
Centre Georges-François Leclerc RECRUITING Dijon 21000 France Details
Centre Léon Bérard RECRUITING Lyon 69008 France Details
Institut régional du Cancer de Montpellier RECRUITING Montpellier 34298 France Details
Centre Antoine Lacassagne RECRUITING Nice 06189 France Details
Institut Jean Godinot RECRUITING Reims 51100 France Details
Centre Henri Becquerel RECRUITING Rouen 7600 France Details
Institut de cancérologie Strasbourg Europe - ICANS RECRUITING Strasbourg 67200 France Details
Gustave Roussy RECRUITING Villejuif 94805 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field